bpc 157 and depression with snac Peptide Therapy for Depression: Can CJC-1295 BPC-157 Improve Mental Heal or Harm: Body Protective
Description
The final word on BPC-157, sitting at the intersection of science and personal experience and public opinion, has yet to be written

Available in both 5mg and 10mg strengths, AOD-9604 is studied in controlled research environments to better understand molecular interactions associated with peptide signaling, intracellular communication, and biochemical regulatory mechanisms

The physiology of glucagonlike peptide 1

Unlike full growth hormone therapy, it does not raise IGF1 (Insulin-like Growth Factor 1) and does not cause systemic growth effects

Is it still safe to use

In limited cutaneous SSc (lcSSc) there is no skin involvement proximal to the elbows and the knees (with the exception of the face and neck areas that can be involved), while diffuse cutaneous SSc (dcSSc) affects the skin in proximal areas such as the trunk
